Residency · Residency · Nuclear Medicine

Medical Events and Misadministrations

Introduction

A medical event, formerly termed a misadministration, is a significant deviation from the intended radiation treatment that meets specific NRC reporting criteria under 10 CFR 35.3045. Medical events must be reported regardless of whether the patient was actually harmed. Understanding the precise definition, reporting obligations, root cause analysis methodology, and prevention strategies is critical for all nuclear medicine practitioners, as these events carry regulatory, clinical, and institutional consequences.

Definition of a Medical Event

NRC Criteria (10 CFR 35.3045)

A medical event occurs when an administration that requires a written directive results in any of several defined deviations. These include delivery of a dose to the wrong patient or to the wrong anatomic site, use of the wrong radiopharmaceutical or the wrong route of administration, an administered dosage or dose that differs from the written directive by more than 20% or falls outside the prescribed range, and a total dose exceeding 0.05 Sv (5 rem) effective dose equivalent to an unintended organ that also exceeds 50% of the dose expected from the prescribed administration.

What Is NOT a Medical Event

Several situations do not meet the threshold for a medical event. Diagnostic administrations do not require written directives and are therefore not subject to medical event reporting. Doses that fall within the 20% tolerance specified in the written directive are considered acceptable. Deviations that are promptly identified and corrected before the administration is completed, with an amended written directive documented, do not constitute medical events. Patient interventions, such as a patient vomiting a therapeutic capsule, are also excluded from the definition.

Reporting Requirements

Timeline

When a medical event is discovered, the NRC Operations Center must be notified by telephone no later than the next calendar day. A written report must be submitted to the NRC regional office within 15 calendar days. The referring physician must be notified within 24 hours of discovery, and the patient or responsible party must also be notified within 24 hours unless the referring physician determines that such notification would be harmful to the patient.

Written Report Content

The written report must include a description of the event and its cause, the actual or projected dose effect on the patient, and the actions taken to prevent recurrence. Patient identity may be withheld from the NRC report but must be provided to the NRC upon request. All records related to the medical event must be retained for 3 years.

Agreement State Reporting

Agreement states may impose additional or different reporting requirements beyond the federal framework. Licensees must comply with the regulations of their applicable state, and dual reporting to both the NRC and the state may be required in some circumstances.

Common Causes of Medical Events

Radiopharmaceutical Therapy

The most common causes of medical events in radiopharmaceutical therapy include administration to the wrong patient due to failure to verify identity by two methods, wrong dose resulting from calculation errors, assay errors, or incorrect radiopharmaceutical concentration, wrong radiopharmaceutical due to labeling errors in the hot lab, wrong route of administration such as intravenous versus oral errors, and dose calibrator malfunction leading to incorrect activity measurement.

I-131 Therapy-Specific Errors

I-131 therapy introduces particular vulnerabilities including capsule or liquid measurement errors, failure to update the written directive after a dose modification, incorrect thyroid remnant ablation dose due to calculation error, and dispensing errors at the radiopharmacy.

Contributing Factors

Systemic factors that contribute to medical events include inadequate staffing or high workload, poor communication between the ordering physician and the nuclear medicine team, lack of standardized verification procedures, inadequate training or supervision, and equipment malfunction without backup verification in place.

Root Cause Analysis

Methodology

Root cause analysis follows a systematic approach. The first step is identifying what happened through a detailed timeline of events. The next step is determining why it happened by distinguishing proximate causes from root causes. System failures are then examined, including gaps in process design, communication, training, equipment, and supervision. Human factors such as fatigue, distraction, confirmation bias, and knowledge deficits are also assessed. The final step is developing corrective actions that address the root causes rather than merely treating symptoms.

Corrective Action Framework

Effective corrective actions include implementing independent two-person verification for high-risk steps, standardizing workflows and checklists, enhancing training and competency assessment, improving labeling and packaging differentiation, and deploying barcode scanning or electronic verification systems.

Prevention Strategies

Procedural Safeguards

Procedural safeguards begin with a time-out before every administration to verify the patient, radiopharmaceutical, dose, and route. Two-person independent verification of both the dose and patient identity should be standard practice. The written directive must be completed and signed before administration begins. Standardized labeling should include the radiopharmaceutical name, activity, date, and patient name on every dose container.

Technology Solutions

Technology-based solutions include barcode-based patient and dose verification systems, unit dose radiopharmacy services that provide pre-verified individual doses, automated dose calibrator logging with electronic records, and electronic written directive systems with built-in verification prompts that guide staff through required checks.

Culture of Safety

A non-punitive reporting environment is essential for encouraging event disclosure and transparency. Regular safety huddles and event review meetings allow the team to learn from incidents collectively. Near-miss reporting and trending help identify systemic vulnerabilities before they result in actual medical events. Annual medical event review should be incorporated into ALARA committee activities as part of the broader radiation safety program.

Impact of Medical Events

Patient Consequences

Most medical events result in minimal or no clinical harm to the patient. However, potential consequences include excessive radiation dose, subtherapeutic treatment requiring retreatment, and unnecessary radiation exposure. The psychological impact of disclosure on the patient should not be underestimated, and medical follow-up may be required for dosimetric assessment to determine the actual dose received.

Institutional Consequences

From an institutional perspective, a medical event may trigger NRC investigation and potential enforcement action, increased regulatory scrutiny with more frequent inspections, mandatory corrective actions and program modifications, and reputational impact with potential litigation.

Clinical Pearls

A medical event is defined by specific NRC criteria under 10 CFR 35.3045 and must be reported regardless of whether actual patient harm occurred. The reporting threshold is the deviation itself, not the clinical outcome.

The NRC Operations Center must be notified by telephone no later than the next calendar day after discovery, with a written report due within 15 calendar days. The referring physician and the patient must each be notified within 24 hours.

Two-person independent verification of patient identity, radiopharmaceutical, and administered activity is the single most effective strategy for preventing medical events. This redundancy catches errors before they reach the patient.

A non-punitive safety culture that encourages reporting of near-misses is essential for identifying systemic vulnerabilities before they result in medical events. Programs that focus on blame rather than system improvement will inevitably under-report and fail to learn from errors.

References

1. U.S. Nuclear Regulatory Commission. "10 CFR 35.3045 -- Report and Notification of a Medical Event." NRC Regulations.
2. U.S. Nuclear Regulatory Commission. "NUREG-1556, Vol. 9, Rev. 3: Consolidated Guidance About Materials Licenses." 2019.
3. Thomadsen BR, et al. "Analysis of Treatment Delivery Errors in Nuclear Medicine Using Root Cause Analysis." J Nucl Med. 2003;44(6):943-951.
4. Siegel JA, et al. "Medical Events in Nuclear Medicine: A Review and Analysis." Health Phys. 2015;108(2):188-196.

Read this lecture as Markdown